BioCorRx (BICX) Non-Current Deferred Tax Liability (2013 - 2024)

BioCorRx has disclosed Non-Current Deferred Tax Liability across 9 years of filings, most recently posting $39349.0 for Q4 2024.

• Non-Current Deferred Tax Liability for Q4 2024 came in at $39349.0, down 80.32% year-over-year; the trailing twelve-month figure through Dec 2024 was $39349.0 (down 80.32% YoY), and the FY2024 annual result was $39349.0, down 80.32% from the prior year.
• Non-Current Deferred Tax Liability came in at $39349.0 for Q4 2024 at BioCorRx, down from $199952.0 in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $361781.0 in Q4 2022 to a low of $39349.0 in Q4 2024.
• The 3-year median for Non-Current Deferred Tax Liability is $199952.0 (2023), against an average of $200360.7.
• Across the five-year window, Non-Current Deferred Tax Liability slumped 44.73% in 2023 and sank 80.32% in 2024, its largest moves.
• BioCorRx's Non-Current Deferred Tax Liability stood at $361781.0 in 2022, then sank by 44.73% to $199952.0 in 2023, then tumbled by 80.32% to $39349.0 in 2024.
• The last three Non-Current Deferred Tax Liability figures came in at $39349.0 (Q4 2024), $199952.0 (Q4 2023), and $361781.0 (Q4 2022), per Business Quant data.